Central Pacific Bank Trust Division Neurocrine Biosciences Inc Transaction History
Central Pacific Bank Trust Division
- $785 Billion
- Q2 2025
A detailed history of Central Pacific Bank Trust Division transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Central Pacific Bank Trust Division holds 1,725 shares of NBIX stock, worth $230,304. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,725
Previous 1,625
6.15%
Holding current value
$230,304
Previous $180 Million
20.64%
% of portfolio
0.03%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding NBIX
# of Institutions
652Shares Held
97.6MCall Options Held
749KPut Options Held
553K-
Black Rock Inc. New York, NY14.2MShares$1.89 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.94MShares$1.33 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.53MShares$739 Million0.37% of portfolio
-
State Street Corp Boston, MA4.86MShares$649 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.67MShares$357 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $12.8B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...